Acidic and basic fibroblast growth factors prolong the in-vitro survival of murine peritoneal macrophages

K V Hackshaw1, A M Trout

  • 1Department of Internal Medicine, Ohio State University, Columbus 43210, USA.

Research Communications in Molecular Pathology and Pharmacology
|June 1, 1996
PubMed

Insights

Acidic (FGF-1) and basic (FGF-2) fibroblast growth factors enhance survival of peritoneal exudate cells in vitro. These findings suggest a role for FGF-1 and FGF-2 in inflammatory and tumor-like conditions.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Immunology

Background:

  • Fibroblast growth factors (FGFs) are crucial signaling molecules involved in various biological processes, including cell proliferation, differentiation, and survival.
  • Angiogenesis, the formation of new blood vessels, is a complex process regulated by growth factors and is implicated in both physiological and pathological conditions such as inflammation and cancer.
  • Peritoneal exudate cells (PECs) are a heterogeneous population of immune cells residing in the peritoneal cavity, playing a role in host defense and inflammatory responses.

Purpose of the Study:

  • To investigate the effects of acidic fibroblast growth factor (FGF-1) and basic fibroblast growth factor (FGF-2) on the survival of murine peritoneal exudate cells (PECs) in vitro.
  • To determine if FGF-1 and FGF-2 influence cellular proliferation and viability during conditions relevant to angiogenic processes.

Main Methods:

  • Murine PECs were cultured in vitro with varying concentrations of FGF-1 or FGF-2, in the presence or absence of heparin.
  • Cell viability was assessed at 24 hours using cell counting and viability assays.
  • Cell proliferation was evaluated by measuring tritiated [3H] thymidine incorporation.
  • Cellular damage was assessed by quantifying lactate dehydrogenase (LDH) release and [3H] uridine incorporation.

Main Results:

  • Supplementation with FGF-1 or FGF-2, in combination with heparin, significantly increased PEC viability compared to heparin alone or medium controls at 24 hours.
  • A slight increase in [3H] thymidine uptake was observed in cultures treated with FGF-1 or FGF-2 plus heparin, indicating a modest proliferative effect.
  • No significant changes in [3H] uridine incorporation or LDH release were detected, suggesting that FGFs did not induce significant DNA/RNA synthesis changes or cell lysis under these conditions.

Conclusions:

  • FGF-1 and FGF-2, particularly when combined with heparin, promote the survival of a subset of peritoneal exudate cells in vitro.
  • These findings suggest that fibroblast growth factors may play a protective role for PECs, potentially influencing inflammatory responses and tumor microenvironments.
  • The observed enhancement of cell survival by FGFs warrants further investigation into their in vivo functions in pathological states.

Related Concept Videos